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Abstract 
Our recent studies revealed that focal basal cell layer disruption (FBCLD) induced 
auto-immunoreactions represented a contributing factor for human prostate tumor pro-
gression and invasion. As the basement membrane surrounds and attaches to the basal cell 
layer, our current study assessed whether FBCLD would impact the physical integrity of the 
associated basement membrane. Paraffin sections from 25-human prostate tumors were 
subjected to double immunohistochemistry to simultaneously elucidate the basal cell layer 
and the basement membrane with corresponding biomarkers. The physical integrity of the 
basement membrane overlying FBCLD was examined to determine the extent of correlated 
alterations. Of a total of 89 FBCLD encountered, 76 (85 %) showed correlated alterations in 
the overlying basement membrane, which included distinct focal disruptions or fragmenta-
tions. In the remaining 13 (15%) FBCLD, the overlying basement membrane showed signifi-
cant attenuation or reduction of the immunostaining intensity. The basement membrane in 
all or nearly all ducts or acini with p63 positive basal cells was substantially thicker and more 
uniform than that in ducts or acini without p63 positive basal cells, and also, a vast majority 
of the focal disruptions occurred near basal cells that lack p63 expression. These findings 
suggest that focal disruptions in the basal cell layer and alterations in the basement mem-
brane are correlated events and that the physical and functional status of the basal cells 
could significantly impact the physical integrity of the overlying basement membrane. As the 
degradation of both the basal cell layer and the basement membrane is a pre-requisite for 
prostate tumor invasion or progression, ducts or acini with focally disrupted basal cell layer 
and basement membrane are likely at greater risk to develop invasive lesions. Thus, further 
elucidation of the specific molecules and mechanism associated with these events may lead 
to the development of a more effective alternative for repeat biopsy to monitor tumor 
progression and invasion. 
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Introduction 
The normal prostate luminal cells, which are the 
histological origin of most prostate malignancies, are 
physically separated from the stroma by the basal 
cells and basement membrane (BM). Basal cells are 
joined by intercellular junctions and adhesion mole-
cules, constituting a continuous sheet encircling lu-
minal cells [1-2]. The BM is composed of type IV col-
lagen, laminins, and other molecules, forming a con-
tinuous lining surrounding and attaching to the basal 
cell layer [3-4]. The epithelium is normally devoid of 
blood vessels and lymphatic ducts, and totally relies 
on the stroma for its metabolic and even survival Int. J. Biol. Sci. 2009, 5 
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needs. Due to these structural relationships, the dis-
ruption of both the basal cell layer and the BM is a 
pre-requisite for prostate tumor invasion.  
It is a commonly held belief that human prostate 
tumor invasion is a multistage process, progressing 
sequentially from normal to hyperplasia, to prostatic 
intraepithelial neoplasia (PIN), and to invasive or 
metastatic stages [5-8]. Progression from PIN to inva-
sion is believed to be triggered by cancer cells that 
increasingly produce proteolytic enzymes with tumor 
progression, which cause degradation of the BM 
[9-10]. These theories are consistent with results of 
studies in tissue cultures and animal models, whereas 
are hard to interpret the following critical facts: (1) 
Our previous studies revealed that some healthy men 
between 19 and 29 years old had a spectrum of pro-
liferative lesions, including hyperplasia, PIN, and 
incipient adenocarcinoma [11-13], (2) Recent studies 
detected a DNA phenotype that is identical to that of 
invasive prostate cancer in some “healthy” men, and 
in morphologically normal prostate tissues adjacent to 
prostate cancer [14-17], (3) A vast majority of PIN ex-
press high levels of proteolytic enzymes, while only 
10-30% of untreated PIN progress to invasive lesions 
during patients’ lifetime [18-21]. Unfortunately, none 
of the current approaches could predict which PIN 
lesions will progress [22-25]. The only established 
approach to monitor PIN progression is repeat biopsy 
[22-25], which is costly and painful, and (4) Results 
from all at clinical trials of prostate cancer treatment 
or prevention with corresponding proteolytic enzyme 
inhibitors have been very disappointing [26-28].   
Together, these facts argue that alternative 
pathways of prostate tumor progression and invasion 
may exist or even play more direct roles. Since over 
90% of prostate cancer related mortality result from 
invasion-related illness, and the incidence of PIN 
could be up to 16.5%-25% prostate biopsies [24-28], 
there is an urgent need to uncover the intrinsic 
mechanism of tumor invasion. Promoted by the fact 
that the basal cell layer is the sole source of tumor 
suppressor p63 and maspin [29-32], and that degra-
dation of basal cell layers is a pre-requisite for tumor 
invasion, our recent studies have attempted to iden-
tify early signs of basal cell degradation. Our initial 
study examined the physical integrity of basal cell 
layers in 50 patients with co-existing pre-invasive and 
invasive prostate tumors. Of 2,047 ducts and acini 
examined, 197 were found to harbor focal disruptions 
(the absence of basal cells resulting in a gap greater 
than the combined size of at least 3 basal cells) in their 
basal cell layers. The frequency of focal basal cell layer 
disruptions (FBCLD) varied from none in 22 cases to 
over 1/3 of the ducts or acini with FBCLD in 17 cases 
[33].  
Compared to their non-disrupted counterparts, 
focally disrupted basal cell layers showed a signifi-
cantly lower frequency of tumor suppressor expres-
sion and proliferation, but a significantly higher rate 
of degeneration and leukocyte infiltration [33]. In 
contrast, epithelial cells overlying focally disrupted 
basal cell layers had a significantly higher rate of pro-
liferation and expression of tumor invasion related 
genes [33-34]. Based on these and other findings, we 
have proposed that prostate tumor invasion or pro-
gression is triggered by FBCLD induced 
auto-immunoreactions, which facilitate formation of 
more aggressive cell clones or monoclonal prolifera-
tion of tumor stem cells overlying focally disrupted 
basal cell layers. Our hypothesis and supporting data 
have been recently published in multiple 
peer-reviewed journals [33-36]. As the basement 
membrane surrounds and attaches to the basal cell 
layer, our current study attempted to assess whether 
FBCLD would impact the physical integrity of the 
associated basement membrane.  
Materials and Methods 
  Formalin-fixed and paraffin embedded tissue 
blocks from 25-human prostate tumors with both 
pre-invasive and invasive components were selected 
from our previous studies [33-36]. Consecutive sec-
tions at 4 μm thickness were prepared and placed on 
positively charged slides. The first and last sections 
f r o m  e a c h  c a s e  w e r e  s t a i n e d  w i t h  h e m a t o x y l i n  a n d  
eosin (H&E) for morphological classification, based 
on our published criteria [11].  
To identify focal basal cell layer disruptions 
(FBCLD), two sections from each case were subjected 
to double immunohistochemistry with basal cell 
phenotypic markers p63 (clone: 4A4; Cell Marque, 
Foster City, CA) at a 1:50 dilution and cytokeratin 
(CK) 34βE12 (clone: M0630; Dako, Carpinteria, CA) 
at a 1:50 dilution according to the manufacturers’ 
protocols. Immunostained sections were examined 
independently by two investigators. A FBCLD was 
defined as the focal absence of basal cells resulting in 
a gap larger than the combined size of at least three 
basal cells in at least two immediate adjacent sections.   
 To identify the potential impact of FBCLD on the 
physical integrity of the associated basement mem-
brane, two sections immediate adjacent to double 
immunostained ones that harbored FBCLD from each 
case were subjected to double immunohistochemistry 
to simultaneously elucidate the basal cell layer and 
the basement membrane using a previously published 
protocol. Briefly, deparaffinized sections were incu-
bated in 1X antigen retrieval solution (Cat #: Int. J. Biol. Sci. 2009, 5 
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RV1000M; Biocare Medical, Concord, CA) overnight 
(?) at 70℃ in a regular oven. After incubation, the 
sections were washed in tap water and PBS (pH 7.4), 
each for 5-10 minutes, and then, incubated with anti-
bodies to p63 (at a 1:50 dilution) and CK 34βE12 (at a 
1:50 dilution) for 2-3 hours at room temperature. After 
the incubation, the sections w e r e  w a s h e d  i n  t h r e e  
changes of PBS, each for 2-3 minutes, and then, incu-
bated with the corresponding secondary antibody. 
The antigen and antibody complex was detected with 
an ABC detection kit and a DAB chromogen kit 
(Vector Laboratories, Burlingame, CA), according to 
the instructions provided by the manufacturer. After 
chromogen reaction, the sections were washed in tap 
water and PBS, each for 5-10 minutes. Then, the sec-
tions were incubated with proteinase K ready-to-use 
solution (Cat #: S3020; Dako, Carpinteria, CA) at room 
temperature for 3-5 minutes. After the proteinase K 
digestion, sections were incubated with mouse 
monoclonal antibodies to collagen IV (clone: CIV 22; 
Dako; Carpinteria, CA) at a 1:50 dilution or laminin 
(clone: VP-L551; Vector Laboratories, Burlingame, 
CA) at a 1:25 dilution at room temperature for 2-3 
hours. After the incubation, the sections were washed 
in three changes of PBS, each for 2-3 minutes, and 
then, incubated with the corresponding secondary 
antibody. The antigen and antibody complex was 
detected with an ABC detection kit and an AP 
red-chromogen kit (Cat #: 00-2203; Zymad, South San 
Francisco, CA) according to the instructions provided 
by the manufacturers.  
 To assess the specificity of the immunostaining, 
three technical approaches were used. First, different 
negative controls were used, which included (1) the 
substitution of the primary antibody with normal 
serum, (2) the omission of the secondary antibody 
from the immunostaining sequence, (3) serial dilu-
tions of the primary antibody, and (4) the inclusion of 
sections from normal lymph-nodes in the normal 
immunostaining process. Second, the same immu-
nostaining protocol was used on the same cases, but 
substituting with different detection system and sub-
strates. Third, the immunostaining procedure was 
repeated at least twice using the same protocol and 
under the same condition and immunostained sec-
tions were independently evaluated by at least two 
investigators.  
 Using p63 and CKβE12 double immunostained 
sections as references, the corresponding sites of 
FBCLD in sections double immunostained for both 
basal cell phenotypic and basement membrane 
markers were photographed, and large prints were 
made and examined, to determine whether alterations 
in the basal cell layer and the basement membrane are 
correlated events. Correlated alterations of the basal 
cell layer and basement membrane were defined as a 
simultaneous focal loss of both structures on the same 
sites.  
Results  
 Distinct immunoreactivities to p63 or CKβE12 
were exclusively seen in basal cells. Distinct immu-
noreactivities to collagen or laminin were preferen-
tially seen in the basement membrane, but were also 
seen in the stroma and blood vessels, which contain 
abundant collagen and laminin as structural elements. 
All negative controls completely lacked distinct im-
munoreactivities to any of the markers used.  
 In sections double immunostained for basal cell 
phenotypic and basement membrane markers, both 
p63 and CKβE12 could elucidate the basal cell layer, 
while p63 appeared to be able to better differentiate 
between the basal cell layer from the basement mem-
brane (Fig 1). A vast majority of the ducts and acini 
with normal morphology or with hyperplastic or PIN 
lesions contained a non-disrupted basal cell layer and 
a continuous basement membrane, whereas their ad-
jacent invasive lesions laced both (Fig 1). The physical 
integrity of the basal cell layer and basement mem-
brane appeared to be largely independent of the duc-
tal or acinar lumen or tumor size (Fig 1e-1h).  
  Of a total of 89 FBCLD encountered, 76 (85 %) 
showed focal disruption or fragmentations in the 
overlying basement membrane (Table 1), whereas 
none showed the integrity of basement membrane is 
impaired while the basal cell layer is normal. Over 
60% of the focal disruptions in both the basal cell layer 
and the overlying basement membrane were seen in 
PIN (Fig 2), while about 30% of these focal disruptions 
were seen in ducts or acini with benign morphology 
(Fig 3). The size of these focal disruptions varied sub-
stantially, from a few cells (Fig 2a-2d) to more than a 
half of the entire basal cell layer and the basement 
membrane (Fig 2e-2h). The size of these focal disrup-
tions in normal or hyperplastic lesions was generally 
small and varied in numbers (Fig 3).  
 The basement membrane overlying the remain-
ing 13 (15%) FBCLD showed significant attenuation or 
reduction of the immunostaining intensity, compared 
to its adjacent counterpart overlying the 
non-disrupted basal cell layer (Fig 4). The basement 
membrane in all or nearly all ducts or acini with p63 
positive basal cells was substantially thicker and more 
uniform than that in ducts or acini without p63 posi-
tive basal cells (Fig 4a-4b), and also, a vast majority of 
the focal disruptions occurred near basal cells that 
lack p63 expression (not shown).  Int. J. Biol. Sci. 2009, 5 
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Table 1. Correlated alterations in basal cell layer and overlying basement membrane 
Total FBCLD  With loss of BM  Without loss of BM   p 
 89   76 (85%)   13 (15%)   < 0.01 
 
 
 
Figure 1. Basal cell layer and basement membrane in benign prostatic ducts and acini. Sections were double immunostained 
with basal cell phenotypic and basement membrane specific markers. Note that the luminal cells of most benign ducts or 
acini are surrounded by a non-disrupted basal cell layer (thin arrows) and a continuous basement membrane (thick arrows). 
a, c, e, and g: 100X; b, d, f, and h: a higher (400X) magnification of a, c, e, and g, respectively. Int. J. Biol. Sci. 2009, 5 
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Figure 2. Correlated focal loss of basal cell layer and basement membrane in PIN. Sections were double immunostained 
with basal cell phenotypic and basement membrane specific markers. Thick arrows identify correlated focal disruption in the 
basal cell layer and the overlying basement membrane. Thin arrows identify the residual basal cell layer and basement 
membrane. Note that the size of focal disruptions varies from a few cells (a-d) to over a half of the entire basal cell layer and 
the basement membrane (e-h). a, c, e, and g: 100X; b, d, f, and h: a higher (400X) magnification of a, c, e, and g, respectively. Int. J. Biol. Sci. 2009, 5 
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Figure 3. Correlated focal loss of basal cell layer and basement membrane in PIN. Sections were double immunostained 
with basal cell phenotypic and basement membrane specific markers. Thick arrows identify correlated focal disruption in the 
basal cell layer and the overlying basement membrane. Thin arrows identify the residual basal cell layer and basement 
membrane. Note that although most ducts or acini harbor only one small focal disruption (a-b), while some contain multiple 
focal disruptions (g-h). a, c, e, and g: 100X; b, d, f, and h: a higher (400X) magnification of a, c, e, and g, respectively. Int. J. Biol. Sci. 2009, 5 
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Figure 4. Attenuation of basement membrane in areas lacking p63 expressing basal cells. Sections were double immu-
nostained with basal cell phenotypic and basement membrane specific markers. Thin arrows identify the attenuated base-
ment membrane in a small duct (b) and areas lacking p63 expressing cells. Thick arrows identify the basement membrane 
adjacent to p63 expressing cells. a, c, and e: 100X; b, d, and f: a higher (400X) magnification of a, c, and e, respectively. 
 
 
Discussion 
 The pattern and frequency of FBCLD seen in our 
current study are in total agreement with those of our 
previous studies, and also those from other groups. 
Our findings of the loss or fragmentations of the 
basement membrane are also in line with previous 
reports. To our best knowledge, our finding of corre-
lated alterations in the basal cell layer and the under-
lying basement membrane, and malig-
nancy-associated morphologic alterations (focal dis-
ruptions in both the basal cell layer and basement 
membrane) in morphologically normal or hyperplas-
tic duct or acinar clusters, however, have not been Int. J. Biol. Sci. 2009, 5 
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previously reported.  
 Since the epithelium is normally devoid of both 
blood vessels and lymphatic ducts, and the basal cell 
layer is the sole source of several tumor suppressors 
[29-32], a focal disruption in the basal cell layer and its 
underlying basement membrane could potentially 
have a number of consequences, including: (1) a loss 
or reduction of tumor suppressors and the paracrine 
inhibitory functions, which allow the luminal cells to 
undergo elevated proliferation [37-41], (2) alterations 
in the permeability for oxygen or growth factors, 
which selectively triggers the exit of stem or progeni-
tor cells from quiescence, and favor proliferation of 
cells overlying FBCLD [42-44], (3) the exposure of 
luminal cells to different cytokines, which facilitates 
vasculogenic mimicry and tumor angiogenesis 
[45-46], (4) the physical contact between luminal and 
stromal cells, which augments the expression of 
stromal MMP and facilitates epithelial-mesenchymal 
transition and cell motility [47-49], and (5) the physi-
cal contact between luminal and immunoreactive 
cells, which directly causes genomic or cellular dam-
ages that trigger a cascade reaction of malignant 
transformation [50-55]. These alterations could indi-
vidually or collectively trigger elevated proliferation 
in luminal cells near FBCLD, which leads to the 
enlargement of FBCLD and stretching-out of the re-
sidual basal cell layer and basement membrane. 
Eventually, the entire basal cell layer and basement 
membrane becomes dissociated or degenerated (as 
those shown in Fig 2e-2h), which facilitates invasion 
or progression of the overlying tumor cells. Thus, 
ducts or acini with focal disruptions in both the basal 
cell layer and the underlying basement membrane are 
very likely at greater risk to develop invasive prostate 
lesions. Consequently, the development of more 
practical and quantitative methods to assess the 
physical and functional integrity of the basal cell layer 
and basement membrane may lead to the develop-
ment of a more effective alternative for repeat biopsy 
to monitor tumor progression and invasion. More 
importantly, our findings suggest that in addition to 
the multistage model, in which prostate carcinogene-
sis is believed to be sequentially progressing from 
normal, to hyperplasia, to high grade PIN, and to in-
vasive lesions, prostate tumor invasion could poten-
tially take place at any stage, if a focal disruption of 
the basal cell layer and the basement membrane 
happens to occur near a tumor progenitor [34-36].  
  The underling mechanism for the correlated al-
terations in the basal cell layer and the underlying 
basement membrane is unknown, but is likely to re-
sult from focal degeneration of aged or injured basal 
cells and resultant auto-immunoreactions. The basal 
cell belongs to a self-renewal population that has to 
consistently undergo proliferation and differentiation 
to replace aged or injured cells. A number of external 
or internal insults, such as radiation, carcinogens, lo-
calized trauma, inflammation, or other factors, could 
cause the inactivation of, or defects, in basal cell re-
newal-related genes, which impair the basal cell re-
plenishment process to replace the aged or injured 
basal cells, resulting in a “senesced” basal cell popu-
lation. These “senesced” basal cells may have signifi-
cantly reduced functions to produce the major build-
ing blocks of the basement membrane or may have 
significantly reduced affinity in their surface to attract 
the deposition of collagen, laminin, and other build-
ing elements of the basement membrane. Consistent 
with this possibility is the fact that the basement 
membrane in all or nearly all ducts or acini with p63 
positive basal cells was substantially thicker and more 
uniform than that in ducts or acini without p63 posi-
tive basal cells (Fig 4a-4b), and also, a vast majority of 
the focal disruptions occurred near basal cells that 
lack p63 expression.  
In summary, our current study reveals for the 
first time that the basement membrane underlying all 
focally disrupted basal cell layers encountered 
showed either correlated focal disruptions (85%) or 
substantial attenuation (15%), suggesting that the 
functional or physical status of the basal cells signifi-
cantly impact the physical integrity of the associated 
basement membrane. As the degradation of both the 
basal cell layer and the basement membrane is a 
pre-requisite for prostate tumor invasion or progres-
sion, ducts or acini with focally disrupted basal cell 
layer and basement membrane are likely at greater 
risk to develop invasive lesions. Thus, further eluci-
dation of the specific molecules and mechanism asso-
ciated with these events may lead to the development 
of a more effective alternative for repeat biopsy to 
monitor tumor progression and invasion. 
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